Mark Danese

11PUBLICATIONS
1CO-AUTHORS
Latin and classical Greek languagesCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Haematological tumoursData models, storage and indexing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 06, 2025
Response to Liu, Xiao, Liu, et al.

Mark D Danese, John S Groundland

|Sep 20, 2024
Effect of chemotherapy and surgery timing on mortality in upper and lower extremity osteosarcoma.

Mark D Danese, John S Groundland

|Apr 29, 2022
Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UK.

Mark Danese, Eduard Sidelnikov, Guillermo Villa

|Apr 17, 2022
Association Between Granulocyte Colony-Stimulating Factor (G-CSF) Use and Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Among Elderly Patients with Breast, Lung, or Prostate Cancer.

Mark D Danese, Jennifer Schenfeld, Jaime Shaw

|Jan 27, 2022
Real-world outcomes with second-line therapy in advanced esophageal squamous cell carcinoma using SEER-Medicare data.

Mark Danese, Joseph Gricar, Pranav Abraham

|Dec 18, 2020
A comparison of mixture cure fraction models to traditional parametric survival models in estimation of the cost-effectiveness of nivolumab for relapsed small cell lung cancer.

Joshua A Roth, Yong Yuan, Megan Othus

Pageof 2

Frequent Collaborators

1 joint publications

Joshua A Roth